Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bastian BC (2003) Hypothesis: a role for telomere crisis in spontaneous regression of melanoma. Arch Dermatol 139: 667–668
Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163: 1765–1770
Bogdan I, Smolle J, Kerl H, Burg G, Boni R (2003) Melanoma ex naevo: a study of the associated naevus. Melanoma Res 13: 213–217
Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3: 559–570
Collisson EA, De A, Suzuki H, Gambhir SS, Kolodney MS (2003) Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade. Cancer Res 63: 5669–5673
Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D, Torre GD, Perrone F, Luoni C, Suardi S, Frattini M, Pilotti S, Anichini A, Tragni G, Parmiani G, Pierotti MA, Rodolfo M (2004) BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 23: 5968–5977
Fedorov LM, Papadopoulos T, Tyrsin OY, Twardzik T, Gotz R, Rapp UR (2003) Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch. Cancer Res 63: 2268–2277
Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA (2000) Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 92: 1006–1010
Hahn WC, Weinberg RA (2002) Modelling the molecular circuitry of cancer. Nat Rev Cancer 2: 331–341
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70
Hatakeyama M, Weinberg RA (1995) The role of RB in cell cycle control. Prog Cell Cycle Res 1: 9–19
Houben R, Becker JC, Kappel A, Terheyden P, Brocker EB, Goetz R, Rapp UR (2004) Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog 3: 6
Kumar R, Angelini S, Czene K, Sauroja I, Hahka-Kemppinen M, Pyrhonen S, Hemminki K (2003) BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res 9: 3362–3368
Kumar R, Angelini S, Snellman E, Hemminki K (2004) BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122: 342–348
Masutomi K, Yu EY, Khurts S, Ben Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC (2003) Telomerase maintains telomere structure in normal human cells. Cell 114: 241–253
Mercer KE, Pritchard CA (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653: 25–40
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nat Genet 33: 19–20
Rangarajan A, Hong SJ, Gifford A, Weinberg RA (2004) Species-and cell type-specific requirements for cellular transformation. Cancer Cell 6: 171–183
Sagebiel RW (1993) Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol 100: 322S–325S
Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 100: 7737–7742
Smolle J, Kaddu S, Kerl H (1999) Non-random spatial association of melanoma and naevi—a morphometric analysis. Melanoma Res 9: 407–412
Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH, Jr (2002) A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 94: 3192–3209
Tucker MA, Goldstein AM (2003) Melanoma etiology: where are we? Oncogene 22: 3042–3052
Tuveson DA, Weber BL, Herlyn M (2003) BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell 4: 95–98
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789–799
Weinberg RA (1996) How cancer arises. Sci Am 275: 62–70
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Becker, J.C., Georgii, S., Houben, R. (2005). Vom Nävus zum Melanom. In: Plewig, G., Kaudewitz, P., Sander, C.A. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28691-8_4
Download citation
DOI: https://doi.org/10.1007/3-540-28691-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21055-9
Online ISBN: 978-3-540-28691-2
eBook Packages: Medicine (German Language)